Barely Significant
← all excerpts

Evaluation of the efficacy and safety of rivaroxaban compared to warfarin in patients with left ventricular apical thrombus: a randomized clinical trial.

Thromb J · 2024 · PMC11264466 · PMID 39030573

1
hedged sentence
closest p
boldest claim

The sentences

showed a trendno p-value reported
Notably, patients with good control showed a trend toward greater thrombus resolution (81.8% resolution) compared to those with sub-optimal control (0% resolution) over the follow-up period (comparison between groups was conducted using Independent Samples t-test and crosstabs with Chi-square-test, p-value = 0.001).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.